anticd206 antibody Search Results


mouse mmr/cd206 antibody  (Bio-Techne corporation)
96
Bio-Techne corporation mouse mmr/cd206 antibody
Mouse Mmr/Cd206 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/bio-techne+corporation___af2535?v=Bio-Techne+corporation
Average 96 stars, based on 1 article reviews
mouse mmr/cd206 antibody - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
cd206  (Boster Bio)
94
Boster Bio cd206
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Cd206, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/pm40446580-100-10-13?v=Boster+Bio
Average 94 stars, based on 1 article reviews
cd206 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
anti cd206 antibody  (Boster Bio)
92
Boster Bio anti cd206 antibody
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Anti Cd206 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/pmc12360003-51-1-13?v=Boster+Bio
Average 92 stars, based on 1 article reviews
anti cd206 antibody - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier
anti-cd206 antibody  (FineTest Biotech Inc)
90
FineTest Biotech Inc anti-cd206 antibody
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Anti Cd206 Antibody, supplied by FineTest Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/pmc11686397__41467_2024_55303_MOESM1_ESM-25-48-52?v=FineTest+Biotech+Inc
Average 90 stars, based on 1 article reviews
anti-cd206 antibody - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anticd206 antibody  (Medac GmbH)
90
Medac GmbH anticd206 antibody
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Anticd206 Antibody, supplied by Medac GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/pm31825135-76-10-19?v=Medac+GmbH
Average 90 stars, based on 1 article reviews
anticd206 antibody - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human mmr/cd206 antibody  (Bio-Techne corporation)
99
Bio-Techne corporation human mmr/cd206 antibody
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Human Mmr/Cd206 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/bio-techne+corporation___af2534?v=Bio-Techne+corporation
Average 99 stars, based on 1 article reviews
human mmr/cd206 antibody - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
boster biological technology co  (Boster Bio)
89
Boster Bio boster biological technology co
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Boster Biological Technology Co, supplied by Boster Bio, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/pm41453474-37-22-22?v=Boster+Bio
Average 89 stars, based on 1 article reviews
boster biological technology co - by Bioz Stars, 2026-06
89/100 stars
  Buy from Supplier
mmr/cd206/mannose receptor antibody  (Bio-Techne corporation)
94
Bio-Techne corporation mmr/cd206/mannose receptor antibody
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Mmr/Cd206/Mannose Receptor Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/bio-techne+corporation___nbp1-90020?v=Bio-Techne+corporation
Average 94 stars, based on 1 article reviews
mmr/cd206/mannose receptor antibody - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
anti-ha tag monoclonal antibody  (OriGene)
93
OriGene anti-ha tag monoclonal antibody
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Anti Ha Tag Monoclonal Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/origene___ta100012?v=OriGene
Average 93 stars, based on 1 article reviews
anti-ha tag monoclonal antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
fitc-conjugated rat anti-cd206 antibodies  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc fitc-conjugated rat anti-cd206 antibodies
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Fitc Conjugated Rat Anti Cd206 Antibodies, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/10__1096_slash_fj__202100157rr-59-19-26?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
fitc-conjugated rat anti-cd206 antibodies - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
itc –cd206  (RayBiotech inc)
90
RayBiotech inc itc –cd206
Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and <t>CD206</t> (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.
Itc –Cd206, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anticd206+antibody/10__1016_slash_j__apmt__2021__101310-84-10-13?v=RayBiotech+inc
Average 90 stars, based on 1 article reviews
itc –cd206 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and CD206 (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Article Title: Poliumoside alleviates microglia-mediated inflammation and blood-brain barrier disruption via modulating the polarization of microglia after ischemic stroke in mice.

doi: 10.1016/j.phymed.2025.156881

Figure Lengend Snippet: Fig. 3. Pol attenuated microglial activation in vivo after stroke. (A-B). Representative images of Iba1 and CD16/32 (A) and CD206 (B) labeled brain tissue on day 1 after stroke; (D) Microglial endpoints/cell; (E) Process length/cell of microglia; the ratio of CD16/32+ (C) and CD206+ (F) cells(n = 4–5); (G-I) Western blot bands of iNOS, CD86, Arg-1 and CD206 in the brain on day 1 after stroke and β-actin internal control-based optical density quantification(n = 4–5). Bar= 20 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. ^p < 0.05, ^^p < 0.01, ^^^p < 0.001, ^^^^p < 0.0001 tMCAO vs sham group; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Pol-M vs tMCAO group; #p < 0.05, ##p < 0.01,### p < 0.001, ####p < 0.0001 Pol-H vs tMCAO group; $p < 0.05, $$p < 0.01, $$$ p < 0.001, $$$$p < 0.0001 EDB vs tMCAO group, ns = no statistical difference.

Article Snippet: The primary antibody used in this study was: rabbit anti CD206 (1:1000, A02285–2, Boster Biological, China), rabbit anti Arg-1 (1:1000, A01106, Boster Biological, China), rabbit anti iNOS (1:1000, BA0326, Boster Biological, China), rabbit anti CD86 (1:1000, A00220–4, Boster Biological, China), rabbit anti-occludin antibody (1:1000 ab31721, abcam),rabbit anti Claudin 5 Monoclonal AntibodyAlexa FluorTM 488(1:100 Thermo Fisher Scientific),rabbit anti ZO-1 (1:1000,Proteintech,21,773–1 Wuhan, China),rabbit anti p-stat3 (1:2000, 9145T,CST),mouse anti Stat3 (1:1000,9139,CST),while the secondary antibody was either rabbit anti-mouse IgG (H + L) or rabbit anti-rabbit IgG (Abbkine, CA, USA).

Techniques: Activation Assay, In Vivo, Labeling, Western Blot, Control

Fig. 4. Pol regulates BV2 cell polarization in vitro. (A) Workflow of vitro experiment. (B) CCK8 assay was used to detect the toxicity of Pol on BV2 cells (n = 5); (C-D) The levels of IL-6 and TNFα mRNA in BV2 cells(n = 4), (E-G)) Levels of Inflammatory cytokine in BV2 cell culture (n = 4–5); (H-I) The levels of M1 type genes CD86, COX-2, (J-K) The levels of M2 type genes CD206, Arg-1 in BV2 cells (n = 4); (L-M) Immunofluorescence detection of BV2 cell polarization representative images and data visualization (n = 4); (N–O) Flow cytometry detection of BV2 cell polarization (n = 4). (P-Q) Apoptosis of neurons(n = 3). Bar= 100 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. *p < 0.05, **p < 0.01, ****p < 0.0001; ns= no statistical ifference.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Article Title: Poliumoside alleviates microglia-mediated inflammation and blood-brain barrier disruption via modulating the polarization of microglia after ischemic stroke in mice.

doi: 10.1016/j.phymed.2025.156881

Figure Lengend Snippet: Fig. 4. Pol regulates BV2 cell polarization in vitro. (A) Workflow of vitro experiment. (B) CCK8 assay was used to detect the toxicity of Pol on BV2 cells (n = 5); (C-D) The levels of IL-6 and TNFα mRNA in BV2 cells(n = 4), (E-G)) Levels of Inflammatory cytokine in BV2 cell culture (n = 4–5); (H-I) The levels of M1 type genes CD86, COX-2, (J-K) The levels of M2 type genes CD206, Arg-1 in BV2 cells (n = 4); (L-M) Immunofluorescence detection of BV2 cell polarization representative images and data visualization (n = 4); (N–O) Flow cytometry detection of BV2 cell polarization (n = 4). (P-Q) Apoptosis of neurons(n = 3). Bar= 100 μm. Data are presented as means ± SD, were performed by One-way ANOVA followed by Tukey’s multiple comparisons test. *p < 0.05, **p < 0.01, ****p < 0.0001; ns= no statistical ifference.

Article Snippet: The primary antibody used in this study was: rabbit anti CD206 (1:1000, A02285–2, Boster Biological, China), rabbit anti Arg-1 (1:1000, A01106, Boster Biological, China), rabbit anti iNOS (1:1000, BA0326, Boster Biological, China), rabbit anti CD86 (1:1000, A00220–4, Boster Biological, China), rabbit anti-occludin antibody (1:1000 ab31721, abcam),rabbit anti Claudin 5 Monoclonal AntibodyAlexa FluorTM 488(1:100 Thermo Fisher Scientific),rabbit anti ZO-1 (1:1000,Proteintech,21,773–1 Wuhan, China),rabbit anti p-stat3 (1:2000, 9145T,CST),mouse anti Stat3 (1:1000,9139,CST),while the secondary antibody was either rabbit anti-mouse IgG (H + L) or rabbit anti-rabbit IgG (Abbkine, CA, USA).

Techniques: In Vitro, CCK-8 Assay, Cell Culture, Immunofluorescence, Flow Cytometry